INFLUENZA COVID-19 COMBINATION vaccine

Study background

Influenza, commonly called the flu, is a highly contagious virus and is one of the leading causes of death in the world. 300,000 Australians were infected with the flu in 2019 and older adults are at a greater risk of serious complications, such as lung and heart diseases.

COVID-19 is also a highly infectious virus that has been the cause of the current pandemic. COVID-19 vaccines are now currently available for the public, however, there is suggestion that there is potential seasonal circulation and may require the need of an annual booster.

This research study is being conducted as there is a need for a combination vaccine of Influenza and COVID-19 to ensure there is constant protection annually when the viruses are in circulation. The combination vaccine of Influenza and COVID-19 will make it easier to receive protection against both viruses in one vaccine rather than receiving the vaccines individually.

Study Details

The study would require you to come to the clinic 8 times over 6 months. Visits will range between 15 mins to 90 minutes each time you come in. Over the course of the study, we will check your medical history, draw blood, and inject the study vaccine. You will also need to complete an app on your phone to record data for 7 days following the vaccinations.

You will be reimbursed for your time and involvement in the research study.

Eligibility criteria

  • Aged between 50 and 70 years
  • Must have completed your second dose of a COVID-19 vaccine 8 weeks or more before this study

Apply Now